Pulmonary Disease · Bethesda, MD
NPI
1790798940
Since 2006
Specialty
Pulmonary Disease
Code 174400000X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
9406 Old Georgetown Rd
Bethesda, MD, 20814
Phone (301) 530-0331
Medicare paid, 2024
$133K
1,496 services
Medicare patients, 2024
408
Average age 77
Drug cost, 2024
$1.7M
1,742 prescriptions
Company payments, 2025
$712
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gita C Bakhshi was code 99214 (office e&m - established), 565 times for 296 patients. In total Gita C Bakhshi billed 1,496 services in 14 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-07-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 565 | 296 | $101.74 | $57K |
| 99215 Office E&M - Established | Office | 247 | 168 | $143.28 | $35K |
| 94010 Pulmonary Function Testing | Office | 199 | 144 | $22.58 | $4,494 |
| 94726 Pulmonary Function Testing | Office | 109 | 101 | $46.57 | $5,076 |
| 94729 Pulmonary Function Testing | Office | 108 | 100 | $47.35 | $5,114 |
| 94060 Pulmonary Function Testing | Office | 108 | 101 | $32.31 | $3,489 |
| 99205 Office E&M - New | Office | 70 | 70 | $173.16 | $12K |
| 99204 Office E&M - New | Office | 50 | 50 | $129.50 | $6,475 |
| 99213 Office E&M - Established | Office | 30 | 29 | $72.94 | $2,188 |
By year: 2022 $140K for 1,665 services; 2023 $150K for 1,549 services; 2024 $133K for 1,496 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gita C Bakhshi prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 206 prescriptions and refills. In total Gita C Bakhshi wrote 1,742 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 206 | 247 | 77 | $5,138 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 175 | 345 | 53 | $213K |
| Breo Ellipta Fluticasone/Vilanterol | 166 | 306 | 46 | $116K |
| Montelukast Sodium Generic | 105 | 275 | 29 | $1,572 |
| Fluticasone Propionate Generic | 88 | 184 | 27 | $2,723 |
| Prednisone Generic | 86 | 138 | 32 | $679 |
| Azithromycin Generic | 79 | 105 | 41 | $1,111 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 69 | 154 | 22 | $63K |
| Arnuity Ellipta Fluticasone Furoate | 52 | 96 | 25 | $18K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 44 | 118 | 20 | $7,155 |
| Incruse Ellipta Umeclidinium Bromide | 43 | 85 | Under 11 | $28K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 39 | 103 | 20 | $8,800 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 32 | 40 | Under 11 | $24K |
| Spiriva Respimat Tiotropium Bromide | 31 | 59 | Under 11 | $29K |
| Symbicort Budesonide/Formoterol Fumarate | 26 | 58 | Under 11 | $14K |
Brand drugs: 1,040 claims; generic drugs: 702 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gita C Bakhshi $712 ($712 in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $101.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $101 |
| Verona Pharma, Inc. VRNA | 3 | $81.09 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $77.41 |
| Astellas Pharma US Inc 4503.T | 2 | $73.8 |
| GlaxoSmithKline, LLC. GSK | 3 | $58.09 |
| Vifor Pharma, Inc. | 2 | $52.13 |
| Genzyme Corporation SNY | 2 | $48.87 |
| United Therapeutics Corporation UTHR | 2 | $40.22 |
| Insmed, Inc. INSM | 2 | $33.4 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $29.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.